Generalized Anxiety Disorder Market: By Therapeutics Type; By Therapies; By devices & By Geography - Forecast 2018-2023 - ResearchAndMarkets.com

July 11, 2018

DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Generalized Anxiety Disorder Market: By Therapeutics Type; By Therapies; By devices & By Geography - Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.

This report identifies the generalized anxiety disorder market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to generalized anxiety disorder market.

Globally North America dominated the market for generalized anxiety disorder in 2015 with highest market share due to higher research and development activities by pharmaceutical industry in the region. North America was followed by Europe as the second largest regional market for generalized anxiety disorder due to higher patients complaining about stressful life style resulting into GAD. However, Asia-Pacific is expected to remain fastest growing regional segment during the period of study due to changing life style and increasing awareness about such diseases in the region.

This report identifies all the major companies operating in the global generalized anxiety disorder market. Some of the major companies’ profiles in detail are as follows:

GlaxoSmithKline Pharmaceuticals Limited Bristol-Myers Squibb Sumitomo Dainippon Pharma Noven Pharmaceuticals, Inc. Actavis Pharmaceutical Company

Key Topics Covered:

1. Generalized Anxiety Disorder - Market Overview

2. Executive Summary

3. Market Landscape

4. Generalized Anxiety Disorder - Market Forces

5. Generalized Anxiety Disorder - Strategic Analysis

6. Generalized Anxiety Disorder Market, By Therapeutics Type

7. Generalized Anxiety Disorder Market, By Geography

8. Generalized Anxiety Disorder - Market Entropy

9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)

For more information about this report visit https://www.researchandmarkets.com/research/7j6pb3/generalized?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005757/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Anxiety Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/11/2018 02:13 PM/DISC: 07/11/2018 02:13 PM


Update hourly